Follow up of Patients With Aortic Aneurysm by Dosage of Circulant Endothelial Progenitor Cells

N/AUnknownNCT02919709

Centre Hospitalier Universitaire de Besancon40 enrolled

Overview

The study aims to investigate the existence of a reliable correlation between the progression of aortic diameters and blood levels of circulant endothelial progenitor cells CD34+ in patients with not surgical aortic aneurysms.

Study Type

INTERVENTIONAL

Allocation

Purpose

PREVENTION

Masking

NONE

Enrollment

Conditions

Thoracic or Abdominal Aortic Aneurysm With no Indication for Surgical Treatment

Interventions

blood takingBIOLOGICAL

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: 1. Patients aged 18 or more. 2. Patients diagnosed with a thoracic or abdominal aortic aneurysm with no indication for surgical treatment (diameters \> 30 mm but \< 50 mm). 3. Patients accepting to sign a specific informed consent. Exclusion Criteria: 1. Unstable coronary artery disease. 2. Congenital heart disease. 3. Any evolving infectious syndrome or viral infection (HIV, HBV or HCV). 4. Any chronic inflammatory or autoimmune disease. 5. Prior administration of G-CSF; EPO; GM-CSF. 6. Liver failure. 7. Prior oncologic disease or ongoing cancer with a life expectancy \< 1 year. 8. Dementia. 9. Pregnancy. 10. Patients aged \< 18.

Locations (1)

CHRU de Besançon

Besançon, France

RECRUITING